Provided by Tiger Trade Technology Pte. Ltd.

Mistras Group Inc

14.67
+0.58004.12%
Post-market: 14.990.3200+2.18%17:53 EST
Volume:106.13K
Turnover:1.55M
Market Cap:462.81M
PE:25.74
High:14.77
Open:14.29
Low:14.14
Close:14.09
52wk High:14.85
52wk Low:7.06
Shares:31.55M
Float Shares:16.81M
Volume Ratio:0.74
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5699
EPS(LYR):0.6000
ROE:8.46%
ROA:4.94%
PB:2.04
PE(LYR):24.45

Loading ...

Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025

GlobeNewswire
·
Feb 06

UK EV Credits Turn MG Into New Earnings Source For Geely

Simply Wall St.
·
Feb 01

Chinese Carmakers Surge in European Market

Deep News
·
Jan 29

MISTRAS Group Names New Executives to Lead Legal, Cash Flow, and Infrastructure

Reuters
·
Jan 28

MISTRAS Group Announces Strategic Leadership Appointments to Advance Governance, Cash Flow Discipline, and Infrastructure Growth

GlobeNewswire
·
Jan 28

Market Chatter: SAIC Starts Sales of MG Hybrid SUV Model in Israel

MT Newswires Live
·
Jan 21

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

GlobeNewswire
·
Jan 09

BRIEF-Mistras Gets NDT Deal From Bechtel for Woodside’s $17.5 Bln LNG Build

Reuters
·
Dec 16, 2025

MISTRAS Group Wins NDT Services Contract for Woodside Louisiana LNG Project

Reuters
·
Dec 16, 2025

Mistras Awarded Ndt Services Contract by Bechtel for Woodside’s $17.5B Louisiana LNG Megaproject

THOMSON REUTERS
·
Dec 16, 2025

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

GlobeNewswire
·
Dec 11, 2025

Standard Chartered-backed Libeara rolls out MG 999 tokenized gold fund in Singapore

cryptonews
·
Dec 09, 2025

December Investment Strategy and Top 10 Stock Picks for Hong Kong Market

Stock News
·
Nov 30, 2025

Press Release: MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor

Dow Jones
·
Nov 18, 2025

Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis

GlobeNewswire
·
Nov 14, 2025

Press Release: Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025

Dow Jones
·
Nov 10, 2025

Press Release: Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

Dow Jones
·
Nov 10, 2025

MG Home Co Sees 1H Parent Pretax Y765.00M

Dow Jones
·
Nov 07, 2025

MISTRAS Group Inc. reports Q3 revenue of $195.5 million and net income of $13.2 million

Reuters
·
Nov 07, 2025

Mistras FY2025 Q3 Earnings Call Summary and Q&A Highlights: Strategic Diversification and Operational Efficiency Drive Growth

Earnings Call
·
Nov 07, 2025